Furthermore, in subjects receiving liraglutide for an average of 4 years, switching to s.c
33 Exenatide, also a GLP-1 receptor agonist, in a NASH mouse model showed an improvement of mitochondrial tricarboxylic acid cycle flux after a 8-week treatment, a significant decrease in insulin resistance, steatosis, hepatocyte lipotoxicity and hepatic triglyceride content as well as lower expression of hepatic lipogenic genes (Srebp1C, Cd36) and genes involved in inflammation and fibrosis
It takes 4-5 weeks for its active ingredient, tirzepatide, to reach a level in the blood we call its steady state where its levels remain consistent and stable in the blood
The math is the same for any reconstituted peptide, including Tirzepatide, Semaglutide, BPC-157, CJC-1295, and Ipamorelin